rs879255564
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPP3PP5_Moderate
The ENST00000258385.8(CHRND):c.820_820+1del variant causes a splice donor, coding sequence change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000171 in 1,461,758 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
CHRND
ENST00000258385.8 splice_donor, coding_sequence
ENST00000258385.8 splice_donor, coding_sequence
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.95
Genes affected
CHRND (HGNC:1965): (cholinergic receptor nicotinic delta subunit) The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.12870012 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PP3
Multiple lines of computational evidence support a deleterious effect 2: max_spliceai, phyloP100way_vertebrate [when was below the threshold]
PP5
Variant 2-232530138-CAG-C is Pathogenic according to our data. Variant chr2-232530138-CAG-C is described in ClinVar as [Pathogenic]. Clinvar id is 18367.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRND | NM_000751.3 | c.820_820+1del | splice_donor_variant, coding_sequence_variant | 7/12 | ENST00000258385.8 | NP_000742.1 | ||
CHRND | NM_001256657.2 | c.775_775+1del | splice_donor_variant, coding_sequence_variant | 6/11 | NP_001243586.1 | |||
CHRND | NM_001311196.2 | c.517_517+1del | splice_donor_variant, coding_sequence_variant | 7/12 | NP_001298125.1 | |||
CHRND | NM_001311195.2 | c.239-1213_239-1212del | intron_variant | NP_001298124.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRND | ENST00000258385.8 | c.820_820+1del | splice_donor_variant, coding_sequence_variant | 7/12 | 1 | NM_000751.3 | ENSP00000258385 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250736Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135590
GnomAD3 exomes
AF:
AC:
1
AN:
250736
Hom.:
AF XY:
AC XY:
1
AN XY:
135590
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461758Hom.: 0 AF XY: 0.0000151 AC XY: 11AN XY: 727180
GnomAD4 exome
AF:
AC:
25
AN:
1461758
Hom.:
AF XY:
AC XY:
11
AN XY:
727180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital myasthenic syndrome 3B Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2001 | - - |
Lethal multiple pterygium syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 06, 2021 | This variant is also known as δ756del2. This variant has been observed in individual(s) with clinical features of autosomal recessive congenital myasthenic syndrome (PMID: 11435464). This variant is not present in population databases (gnomAD no frequency). This variant results in the deletion of part of exon 7 (c.820_820+1del) of the CHRND gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CHRND are known to be pathogenic (PMID: 11435464, 25264167). ClinVar contains an entry for this variant (Variation ID: 18367). Studies have shown that this variant alters CHRND gene expression (PMID: 11435464). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at